InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by REESE DAVID M, Vice-Président Exécutif, Recherche et Développement. Officer active across 1 companies, notably AMGEN INC. Cumulatively, 9 filings have been published. The latest transaction was filed on 5 May 2022 — Retenue fiscale. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations9 total
€128,805575 shares@ €224.00930.0001% mcap6.4% of flow
Common Stock
SEC:0001127602-22-013876:0·
03,897 shares0
Common Stock
SEC:0001127602-22-013352:0·
€43,558184 shares@ €236.72930.0000% mcap2.1% of flow
Common Stock
SEC:0001127602-22-012766:0·
€1m4,995 shares@ €212.49570.0006% mcap52.4% of flow
Common Stock
SEC:0001127602-22-010198:0·
09,989 shares0
Common Stock
SEC:0001127602-22-008139:0·
€396,3512,192 shares@ €180.8169100.0% of flow
Common Stock
SEC:0001127602-21-028367·
€396,3512,192 shares@ €180.81690.0002% mcap19.6% of flow
Common Stock
SEC:0001127602-21-028367:0·
04,006 shares0
Common Stock
SEC:0001127602-21-015366·
04,006 shares0
Common Stock
SEC:0001127602-21-015366:0·
9 of 9 declarations
About REESE DAVID M
David M. Reese is the EVP, Research and Development at AMGEN INC. In this role, he is responsible for leading the company's research and development initiatives. David brings scientific and strategic expertise, thereby contributing to innovation and advancing research projects.
